Dermisonics Net Income from 2010 to 2026
Dermisonics' Net Loss is decreasing with slightly volatile movements from year to year. Net Loss is predicted to flatten to about -4.8 M. For the period between 2010 and 2026, Dermisonics, Net Loss quarterly trend regression had median of (5,084,047) and r-value of (0.35). View All Fundamentals
Check out the analysis of Dermisonics Correlation against competitors. For more detail on how to invest in Dermisonics Stock please use our How to Invest in Dermisonics guide.
Net Loss | First Reported 2010-12-31 | Previous Quarter -4.6 M | Current Value -4.8 M | Quarterly Volatility 1.2 M |
Check Dermisonics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dermisonics' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 3.8 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.04. Dermisonics financial statements analysis is a perfect complement when working with Dermisonics Valuation or Volatility modules.
Dermisonics | Net Income | Build AI portfolio with Dermisonics Stock |
Latest Dermisonics' Net Income Growth Pattern
Below is the plot of the Net Income of Dermisonics over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Dermisonics financial statement analysis. It represents the amount of money remaining after all of Dermisonics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Dermisonics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dermisonics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (5.08 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Dermisonics Net Income Regression Statistics
| Arithmetic Mean | (4,743,484) | |
| Coefficient Of Variation | (25.48) | |
| Mean Deviation | 568,097 | |
| Median | (5,084,047) | |
| Standard Deviation | 1,208,832 | |
| Sample Variance | 1.5T | |
| Range | 5M | |
| R-Value | (0.35) | |
| Mean Square Error | 1.4T | |
| R-Squared | 0.12 | |
| Significance | 0.17 | |
| Slope | (83,864) | |
| Total Sum of Squares | 23.4T |
Dermisonics Net Income History
Other Fundumenentals of Dermisonics
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
About Dermisonics Financial Statements
Investors use fundamental indicators, such as Dermisonics' Net Income, to determine how well the company is positioned to perform in the future. Although Dermisonics' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Currently Active Assets on Macroaxis
When determining whether Dermisonics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dermisonics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dermisonics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dermisonics Stock:Check out the analysis of Dermisonics Correlation against competitors. For more detail on how to invest in Dermisonics Stock please use our How to Invest in Dermisonics guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Medical Devices space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dermisonics. If investors know Dermisonics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dermisonics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Dermisonics is measured differently than its book value, which is the value of Dermisonics that is recorded on the company's balance sheet. Investors also form their own opinion of Dermisonics' value that differs from its market value or its book value, called intrinsic value, which is Dermisonics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dermisonics' market value can be influenced by many factors that don't directly affect Dermisonics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dermisonics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dermisonics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dermisonics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.